Profile data is unavailable for this security.
About the company
Mind Medicine (MindMed) Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. The Company is developing a pipeline of drug candidates, targeting the serotonin, dopamine and acetylcholine systems. This specifically includes pharmaceutically optimized drug products derived from the psychedelic and empathogen drug classes, including lysergic acid diethylamide (LSD), R(-)-methylenedioxymethamphetamine (MDMA) and zolunicant, or 18-methoxycoronaridine (MC), a congener of ibogaine. The Company’s subsidiaries include Mind Medicine, Inc. (MindMed US), HealthMode, Inc., MindMed Pty Ltd., and MindMed GmbH.
- Revenue in CAD (TTM)0.00
- Net income in CAD-77.23m
- Incorporated2010
- Employees50.00
- LocationMind Medicine (MindMed) Inc1166 Alberni Steet, Suite 1604VANCOUVER V6E 3Z3CanadaCAN
- Phone+1 (203) 648-5275
- Fax+1 (888) 848-3972
- Websitehttps://mindmed.co/